Delivery Order SPE2DB22D2214-SPE2DB24FS5ST
Award Date
7/9/24
Potential Completion Date
7/10/24
Potential Value
$9.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on a firm-fixed price basis. The contract has a ceiling value of $6,715.70 and an ultimate completion date of April 25, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract has a ceiling value of $42,350.26 and is a Firm Fixed Price Delivery Order contract with a period of performance through July 16, 2024....
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $7,956.68, was granted on July 3, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of July 5, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of STELARA 90 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $14,751.06, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier to federal agencies. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $17,743.79, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 15, 2025. The award was made on January 14, 2025, and there was no...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $74,751.13 and a completion date of November 8, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGE/ML to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order with a potential value of $44,284.20 and a completion date of March 4, 2024. No set-aside...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGES to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $20,147.10, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the larger Amerisourcebergen Corporation. This contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award is for the delivery of STELARA 90 MG/ML syringes to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA) Troop Support. The prime contractor is Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract has a ceiling value of $18,584.10 and is a Firm Fixed Price Delivery Order, without a set-aside designation. The contract has an ultimate completion date of October 9, 2024 and was awarded on...
This federal contract award is for the delivery of STELARA 45 MG/0.5 ML syringes to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $7,369.92 and an ultimate completion date of December 5, 2024. This order is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...